10.45

2.38% -0.255

Daxor Corporation (DXR)

Overview News Price History Discussions Forecast Dividend History

Daxor Corporation stock is traded at $10.45, with a volume of 709. It is down -2.38% in the last 24 hours and down -0.48% over the past month. Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.

Previous Close:

$10.71

Open:

$10.61

24h Volume:

709

Relative Volume:

0.15

Market Cap:

$61.01M

Revenue:

$503.40K

Net Income/Loss:

$9.17M

P/E Ratio:

5.7706

EPS:

1.8109

Net Cash Flow:

$-604.40K

1W Performance:

-4.13%

1M Performance:

-0.48%

6M Performance:

-17.00%

1Y Performance:

+4.50%

1-Day Range:

$10.43

$10.61

1-Week Range:

$10.40

$11.09

52-Week Range:

$8.56

$14.76

Daxor Corporation Stock (DXR) Company Profile

Name

Daxor Corporation

Sector

Healthcare (1071)

Industry

Medical Instruments & Supplies (57)

Phone

212-330-8500

Address

Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY

Employee

Twitter

@DaxorBVA

Next Earnings Date

2025-03-05

Latest SEC Filings

DXR's Discussions on Twitter

Compare DXR vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DXR Daxor Corporation	10.45	61.01M	503.40K	9.17M	-604.40K	1.8109
ISRG Intuitive Surgical Inc	337.50	120.92B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	156.36	43.08B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	67.91	33.12B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	38.75	32.77B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	195.27	28.33B	5.54B	1.52B	1.74B	10.37

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-16-19	Initiated	Ascendiant Capital Markets	Buy

Daxor Corporation Stock (DXR) Latest News

05:52 AM

Daxor to exhibit blood volume analyzer at dysautonomia conference By Investing.com - Investing.com Nigeria

Jul 07, 2026

Daxor to exhibit blood volume analyzer at dysautonomia conference - Investing.com

Jul 07, 2026

Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas - The Manila Times

Jul 07, 2026

Daxor Corporation Announces First-Time Exhibition at the - GlobeNewswire

Jul 07, 2026

Jul 06, 2026

DXR Q3 2007 Earnings: EPS Surges 326% Above Estimates, Stock Climbs $1.44Earnings Miss Alert - DonanımHaber

Jul 06, 2026

DXRDaxor Corp Options - Finviz

Jul 06, 2026

Jul 02, 2026

DXR Q3 2007 Earnings: Massive EPS Surprise of 325.7% on Reported Earnings of $0.43Quarterly Earnings - DonanımHaber

Jul 02, 2026

Jul 01, 2026

Avoiding Lag: Real-Time Signals in (DXR) Movement - Stock Traders Daily

Jul 01, 2026

Jun 30, 2026